RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC
Viknesvaran Selvarajan(National University of Singapore), Siok‐Bian Ng(National University of Singapore)
Cited by 71
Related Papers
Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients
|Journal of Hematology & Oncology|2015|139